Suppr超能文献

现代乳腺钼靶筛查的结果。

Outcomes of modern screening mammography.

作者信息

Kerlikowske K, Barclay J

机构信息

Department of Epidemiology and Biostatistics, University of California, San Francisco, USA.

出版信息

J Natl Cancer Inst Monogr. 1997(22):105-11. doi: 10.1093/jncimono/1997.22.105.

Abstract

The University of California, San Francisco, Mobile Mammography Screening Program is a low-cost, community-based breast cancer screening program that offers mammography to women of diverse ethnic backgrounds (36% nonwhite) in six counties in northern California. Analysis of data collected on approximately 34,000 screening examinations from this program shows that the positive predictive value and sensitivity of modern screening mammography to be lower for women aged 40 to 49 years compared to women aged 50 and older. This lower performance is due to the lower prevalence of invasive breast cancer in younger women and possibly to age differences in breast tumor biology. Because of this lower performance, women in their forties may be subjected to more of the negative consequences of screening, which include additional diagnostic evaluations and the associated morbidity and anxiety, the potential for detecting and surgically treating clinically insignificant breast lesions, and the false reassurance resulting from normal mammographic results. Since the evidence is not compelling that the benefits of mammography screening outweigh the known risks for women aged 40 to 49 years, women considering mammography screening should be informed of the risks, potential benefits, and limitations of screening mammography, so that they can make individualized decisions based on their personal risk status and utility for the associated risks and potential benefits of screening.

摘要

加利福尼亚大学旧金山分校的移动乳腺钼靶筛查项目是一项低成本的、基于社区的乳腺癌筛查项目,为北加利福尼亚六个县不同种族背景的女性(36%为非白人)提供钼靶检查。对该项目约34000次筛查检查所收集数据的分析表明,与50岁及以上女性相比,现代筛查钼靶对40至49岁女性的阳性预测值和敏感性较低。这种较低的表现是由于年轻女性浸润性乳腺癌的患病率较低,也可能是由于乳腺肿瘤生物学的年龄差异。由于这种较低的表现,四十多岁的女性可能会承受更多筛查的负面后果,包括额外的诊断评估以及相关的发病率和焦虑、检测和手术治疗临床上无意义的乳腺病变的可能性,以及钼靶检查结果正常所带来的错误安心感。由于没有令人信服的证据表明钼靶筛查的益处超过40至49岁女性已知的风险,考虑钼靶筛查的女性应被告知筛查钼靶的风险、潜在益处和局限性,以便她们能够根据个人风险状况以及对筛查相关风险和潜在益处的效用做出个性化决策。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验